Cart
Compound Libraries COVID-19 / SARS-CoV-2

COVID-19 / SARS-CoV-2

All screening collections in this category were designed to meet the requirements from global scientific research institutions and pharmaceutical companies to help speed up anti-COVID-19 drugs development. The compound libraries contain compounds that have been demonstrated to have anti-coronavirus activity or are broad-spectrum antiviral agents and compounds from virtual screening hits based on molecular docking with high affinity to 7 SARS-CoV-2 protein targets and 1 human ACE2.

Cat No. product name
L1710 Anti-COVID-19 Compound Library A unique collection of 2448 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; 2448 compounds
L1711 Anti-COVID-19 compound library (CADD) A unique collection of 362 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 362 compounds
L1712 3CLpro-Targeted compound library (CADD) A unique collection of 161 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 161 compounds
L1713 ACE2-Targeted compound library (CADD) A unique collection of 462 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 462 compounds
L1714 RBD-Targeted compound library (CADD) A unique collection of 206 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 206 compounds
L1715 nsp16-Targeted compound library (CADD) A unique collection of 281 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 281 compounds
L1716 PLpro-Targeted compound library (CADD) A unique collection of 474 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 474 compounds
L1717 RdRP-Targeted compound library (CADD) A unique collection of 464 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 464 compounds
L1718 X Domain-Targeted compound library (CADD) A unique collection of 463 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 463 compounds
L1719 nsp15-Targeted compound library (CADD) A unique collection of 470 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 470 compounds
L6720 Anti-COVID-19 Traditional Chinese Medicine Compound Library A unique collection of 389 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; 389 compounds
Anti-COVID-19 Compound Library
L1710 compounds - 2448
Anti-COVID-19 compound library (CADD)
L1711 compounds - 362
3CLpro-Targeted compound library (CADD)
L1712 compounds - 161
ACE2-Targeted compound library (CADD)
L1713 compounds - 462
RBD-Targeted compound library (CADD)
L1714 compounds - 206
nsp16-Targeted compound library (CADD)
L1715 compounds - 281
PLpro-Targeted compound library (CADD)
L1716 compounds - 474
RdRP-Targeted compound library (CADD)
L1717 compounds - 464
X Domain-Targeted compound library (CADD)
L1718 compounds - 463
nsp15-Targeted compound library (CADD)
L1719 compounds - 470
Anti-COVID-19 Traditional Chinese Medicine Compound Library
L6720 compounds - 389